This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
WellCare Health Arm MeridianRx Unveils Mobile Application
by Zacks Equity Research
WellCare Health (WCG) unit introduces a unique mobile app, Atlas Compass, to assist PBM members to manage their pharmacy health information.
Universal Health's Acute Care Segment Solid, High Debt Ails
by Zacks Equity Research
Riding high on solid segmental performances, Universal Health (UHS) promises to reap great benefits for investors. However, its debt load bothers.
HCA Healthcare to Buy Large Stake in Galen College of Nursing
by Zacks Equity Research
HCA Healthcare (HCA) to purchase the majority interest in Galen College of Nursing for boosting access to nursing education.
Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (CNC) Outperforming Other Medical Stocks This Year?
Humana, Accolade to Team Up for Providing Advanced Healthcare
by Zacks Equity Research
Humana (HUM) ties up with Accolade to meet healthcare needs of employers and their health plan members.
Why is it Worth Keeping Humana (HUM) in Your Portfolio Now?
by Zacks Equity Research
Riding high on robust Medicare business and strategic buyouts, Humana (HUM) looks promising to reap benefits for investors.
Centene (CNC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $57.45, moving +1.57% from the previous trading session.
Here's Why You Should Add Tenet Healthcare to Your Portfolio
by Zacks Equity Research
Riding high on a solid inorganic growth profile and divestitures, Tenet Healthcare (THC) holds ample chances of reaping benefits for investors.
Magellan Health Down Nearly 40%, in a Year: What's Next?
by Zacks Equity Research
Stiff competition and subdued profitability is weighing on shares of Magellan Health (MGLN).
Centene (CNC) Down 9.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Arm of Ensign Group Unit Buys All County Home Care and Hospice
by Zacks Equity Research
A unit of Ensign Group's (ENSG) subsidiary buys the assets of All County Home Care and Hospice to boost its health and hospice portfolio.
Why Anthem (ANTM) is an Attractive Pick for Your Portfolio
by Zacks Equity Research
Banking on a strong revenue stream and strategic efforts, Anthem (ANTM) holds great advantage to reap profitable returns for investors.
Ensign Group Buys Nursing Hub to Expand in South California
by Zacks Equity Research
Ensign Group (ENSG) purchases Downey Care Center to penetrate into Southern Californian region and enrich its portfolio.
Should Value Investors Buy Centene (CNC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Universal Health's (UHS) Q4 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results gain from its healthy top-line growth.
Teladoc (TDOC) Q4 Earnings Meet Estimates, Revenues Beat
by Zacks Equity Research
Teladoc (TDOC) reports lower losses supported by an increase in revenues partly offset by a rise in expenses.
Here's Why You Should Add Ensign Group to Your Portfolio Now
by Zacks Equity Research
Banking on solid growth strategies and increasing revenues, Ensign Group (ENSG) has great potential to offer benefits to investors.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) fourth-quarter results reflect earnings decline due to a decrease in operating revenues.
Zacks.com featured highlights include: Ralph Lauren, Nu Skin, Tilly's, Centene and STAAR
by Zacks Equity Research
Zacks.com featured highlights include: Ralph Lauren, Nu Skin, Tilly's, Centene and STAAR
Here's Why You Should Add Centene (CNC) to Your Portfolio
by Zacks Equity Research
Riding high on solid fourth-quarter results, a robust bottom line and strategic plans, Centene (CNC) has immense potential to reap benefits for yield-seeking investors.
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Here's Why Investing in Molina Healthcare (MOH) Makes Sense
by Zacks Equity Research
Banking on higher net income and a solid 2018 performance, Molina Healthcare (MOH) holds potential as a promising investment option.
Has Centene (CNC) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CNC) Outperforming Other Medical Stocks This Year?
Is Centene (CNC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene's (CNC) Earnings Top Estimates in Q4, Surge Y/Y
by Zacks Equity Research
Centene's (CNC) Q4 earnings ride high on robust revenues, solid acquisitions and stronger Health Insurance Marketplace business.